140
Participants
Start Date
April 2, 2019
Primary Completion Date
June 29, 2026
Study Completion Date
June 29, 2026
Sodium Zirconium Cyclosilicate (SZC) Reduced Dose Level
Sodium Zirconium Cyclosilicate (SZC) Dose: Paediatric dose based on body weight equivalent to an adult 2.5 g
Sodium Zirconium Cyclosilicate (SZC) Dose Level 1 (DL1)
Sodium Zirconium Cyclosilicate (SZC)Paediatric dose based on body weight equivalent to an adult 5 g
Sodium Zirconium Cyclosilicate (SZC) Dose Level 2 (DL2)
Sodium Zirconium Cyclosilicate (SZC) Paediatric dose based on body weight equivalent to an adult 10 g
Sodium Zirconium Cyclosilicate (SZC) Dose Level 3 (DL3)
Sodium Zirconium Cyclosilicate (SZC) Paediatric dose based on body weight equivalent to an adult 15 g
Sodium Zirconium Cyclosilicate (SZC) Dose During 28 Day Maintenance Phase
A 28-day period during which SZC is administered orally once daily (QD) to maintain normokalaemia. A dose titration regimen starting with QD administration of the dose of SZC the participants received TID in the CP will be studied in the MP and continued in the LTMP. The maximum dose that can be used is the calculated body weight equivalent to the 15 g adult dose
WITHDRAWN
Research Site, New York
WITHDRAWN
Research Site, Stony Brook
RECRUITING
Research Site, Baltimore
WITHDRAWN
Research Site, Winston-Salem
RECRUITING
Research Site, Madrid
WITHDRAWN
Research Site, Charlotte
RECRUITING
Research Site, Columbia
WITHDRAWN
Research Site, Atlanta
RECRUITING
Research Site, Birmingham
SUSPENDED
Research Site, Sumy
COMPLETED
Research Site, Akron
RECRUITING
Research Site, Essen
RECRUITING
Research Site, Cincinnati
SUSPENDED
Research Site, Dnipropetrovsk
NOT_YET_RECRUITING
Research Site, Grand Rapids
SUSPENDED
Research Site, Kharkiv Region
RECRUITING
Research Site, St Louis
WITHDRAWN
Research Site, Odesa
TERMINATED
Research Site, Zaporizhzhia
RECRUITING
Research Site, Heidelberg
RECRUITING
Research Site, Beijing
RECRUITING
Research Site, Beijing
WITHDRAWN
Research Site, New Delhi
NOT_YET_RECRUITING
Research Site, Gūrgaon
RECRUITING
Research Site, Shanghai
RECRUITING
Research Site, Shanghai
WITHDRAWN
Research Site, Hefei
RECRUITING
Research Site, Timișoara
RECRUITING
Research Site, Hangzhou
RECRUITING
Research Site, Chongqing
RECRUITING
Research Site, Cluj-Napoca
RECRUITING
Research Site, Changsha
WITHDRAWN
Research Site, Samara
RECRUITING
Research Site, Târgu Mureş
RECRUITING
Research Site, Chengdu
RECRUITING
Research Site, Chengdu
NOT_YET_RECRUITING
Research Site, Bhubaneshwar
COMPLETED
Research Site, Hackensack
RECRUITING
Research Site, Morgantown
RECRUITING
Research Site, Campinas
RECRUITING
Research Site, São Paulo
RECRUITING
Research Site, São Paulo
RECRUITING
Research Site, Calgary
WITHDRAWN
Research Site, Edmonton
WITHDRAWN
Research Site, Vancouver
RECRUITING
Research Site, Montreal
WITHDRAWN
Research Site, Berlin
RECRUITING
Research Site, Bunkyō City
RECRUITING
Research Site, Fuchu-shi
RECRUITING
Research Site, Fukuoka
RECRUITING
Research Site, Kawasaki-shi
RECRUITING
Research Site, Kobe
RECRUITING
Research Site, Matsumoto-shi
RECRUITING
Research Site, Nakagami-gun
RECRUITING
Research Site, Saitama-Shi
RECRUITING
Research Site, Sendai
RECRUITING
Research Site, Shizuoka
COMPLETED
Research Site, Bialystok
WITHDRAWN
Research Site, Krakow
COMPLETED
Research Site, Lodz
RECRUITING
Research Site, Warsaw
RECRUITING
Research Site, Bucharest
WITHDRAWN
Research Site, Bucharest
RECRUITING
Research Site, Esplugues de Llobregat
SUSPENDED
Research Site, Kyiv
RECRUITING
Research Site, Glasgow
RECRUITING
Research Site, Hampshire
COMPLETED
Research Site, Manchester
RECRUITING
Research Site, Nottingham
Lead Sponsor
AstraZeneca
INDUSTRY